GlassScriptPhysician profile
Matthew C Morrey
NPI 1063491975
$206,702.17
in general payments reported to CMS, 2019-2025
31 companies · $48K in 2025
The $48K reported for 2025 was more than what 95% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15K · 2020: $16K · 2021: $3,453 · 2022: $38K · 2023: $50K · 2024: $37K · 2025: $48K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $69K · Royalty Or License: $36K · Travel and Lodging: $13K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $12K · Food and Beverage: $4,727.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $69,375.00 |
| Royalty Or License | $35,760.26 |
| Travel and Lodging | $12,981.10 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $12,000.00 |
| Food and Beverage | $4,727.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Development Corporation | $110,567.15 | 2019-2025 | |
| Encore Medical, LP | $89,918.32 | 2020-2025 | Djo Surgical |
| Corentec America INC | $1,993.33 | 2023 | |
| Orthalign INC | $1,653.46 | 2020-2024 | Orthalign Plus |
| Limacorporate S.P.A. | $618.55 | 2024 | Master Sl Femoral Stem, Delta Cup, Minima Hip |
| Davol INC. | $339.11 | 2021-2023 | |
| Smith+Nephew, INC. | $195.49 | 2024-2025 | Real Intelligence, K-15 Pork |
| Think Surgical, INC. | $154.42 | 2024 | |
| Stryker Corporation | $151.14 | 2019-2022 | |
| Nextstep Arthropedix, LLC | $133.94 | 2019-2020 | |
| Heraeus Medical, LLC. | $120.40 | 2021-2024 | |
| Canon Medical Systems USA, INC. | $119.88 | 2019 | |
| Ermi LLC | $106.66 | 2019-2020 | |
| Motive Health, INC. | $72.68 | 2019 | |
| Onkos Surgical, INC. | $56.41 | 2025 | Eleos Limb Salvage System |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heron Therapeutics, INC. | $55.96 | 2023-2024 | Zynrelef |
| Sanara Medtech INC. | $47.68 | 2023 | Celleraterx |
| Bioventus LLC | $46.86 | 2019-2022 | |
| Arthrex, INC. | $45.06 | 2020 | |
| Orthofix Medical, INC. | $43.53 | 2019-2023 | Physio-Stim, Spinal-Stim, Cervical-Stim |
| Si-Bone, INC. | $39.67 | 2022 | |
| Tracpatch Health, INC | $38.78 | 2020 | |
| Globus Medical, INC. | $35.01 | 2023 | Ankle Fracture System |
| Mallinckrodt Hospital Products INC. | $22.22 | 2020 | |
| Depuy Synthes Sales INC. | $20.52 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $19.76 | 2020 | |
| Horizon Therapeutics Plc | $19.22 | 2020 | |
| Tactile Systems Technology INC | $18.05 | 2025 | Nimbl, Flexitouch Plus |
| Innovation Technologies INC | $17.73 | 2021 | |
| Sanofi-Aventis U.S. LLC | $15.60 | 2020 | |
| Convatec INC. | $15.58 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Morrey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.